StockMarketWire.com - Deltex Medical Group, the global leader in oesophageal Doppler monitoring, is halfway towards its goal of having 30 US hospitals on its platform programme by mid-2016 after adding two further new accounts. The group says these are two of the larger hospitals within a nine hospital system and both completed successful clinical evaluations of the company's ODM products in the first half of the year. The hospital system has put in place a procurement agreement that will allow other member hospitals to move more quickly in future from clinical evaluation to implementation. This is the fourth US hospital system to put such an agreement in place.

The hospitals have indicated an initial probe purchase requirement of 40 and 50 probes per month respectively.

To help the hospitals achieve use of over 100 probes per month each, the company is recruiting two new clinical trainers who will support these new accounts together with a small number of further local accounts. The two new accounts become the second and third platform programme accounts in the company's Mid-Atlantic sales territory established in the final quarter of 2014. These are the fifth and sixth new platform programme accounts that Deltex has secured since September bringing the total number of US platform accounts to 17, including 11 new ones in the year to date, further illustrating the success of the company's ongoing strategy to focus on the US and develop it as its key market.

Chief executive Ewan Phillips said: "The USA continues to be an increasingly important market for us and we see it moving even closer towards becoming our key territory for development as adoption rates continue to outperform our other areas of focus. We look forward to working with the teams at both these new accounts and are pleased to have the tenth and eleventh accounts added to our US platform programme this year and the sixteenth and seventeenth in total. Deltex Medical is now over half way towards our current goal of 30 US hospitals on our platform programme by mid-2016."


At 9:45am: [LON:DEMG] Deltex Medical Group PLC share price was 0p at 4.13p



Story provided by StockMarketWire.com